‘Sec. 1. 22 MRSA §2353, sub-§2, ¶A-1, as enacted by PL 2015, c. 508, §2 and amended by PL 2017, c. 364, §2, is repealed and the following enacted in its place:
A-1. A pharmacist may prescribe and dispense naloxone hydrochloride in accordance with protocols established under Title 32, section 13815 to an individual of any age at risk of experiencing an opioid-related drug overdose.
Sec. 2. 22 MRSA §2353, sub-§2, ¶A-2, as enacted by PL 2017, c. 249, §1 and repealed by c. 364, §3, is repealed.
Sec. 3. 22 MRSA §2353, sub-§2, ¶C-1, as enacted by PL 2015, c. 508, §2 and amended by PL 2017, c. 364, §4, is repealed and the following enacted in its place:
C-1. A pharmacist may prescribe and dispense naloxone hydrochloride in accordance with protocols established under Title 32, section 13815 to a person of any age who is a member of an individual's immediate family or a friend of the individual or to another person in a position to assist the individual if the individual is at risk of experiencing an opioid-related drug overdose.
Sec. 4. 22 MRSA §2353, sub-§2, ¶C-2, as enacted by PL 2017, c. 249, §1 and repealed by c. 364, §5, is repealed.